SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
46.22
+0.10 (0.22%)
May 13, 2025, 4:00 PM - Market closed

SpringWorks Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-253.93-258.13-325.1-277.42-173.91-45.57
Upgrade
Depreciation & Amortization
3.843.471.670.770.490.35
Upgrade
Loss (Gain) on Equity Investments
11.5765.042.890.990.61
Upgrade
Stock-Based Compensation
108.63109.1494.5372.9738.4410.03
Upgrade
Other Operating Activities
1.911.791.651.130.991.05
Upgrade
Change in Accounts Receivable
-24.82-40.31-5.93---
Upgrade
Change in Inventory
-7.2-7.11-3.1---
Upgrade
Change in Accounts Payable
7.854.6-0.24.172.07-1.3
Upgrade
Change in Unearned Revenue
-1.77-1.77-19.55--
Upgrade
Change in Other Net Operating Assets
-11.516.728.6514.393.042.65
Upgrade
Operating Cash Flow
-165.43-175.6-222.8-161.56-127.88-32.19
Upgrade
Capital Expenditures
-3.9-4.45-7.39-10.2-2.02-0.64
Upgrade
Sale (Purchase) of Intangibles
-16.25-16.25----
Upgrade
Investment in Securities
136.6385.2542.14-205.485.61-418.19
Upgrade
Investing Cash Flow
116.4864.5534.75-215.683.59-418.83
Upgrade
Issuance of Common Stock
9.5213.2299.44342.041.16270.49
Upgrade
Repurchase of Common Stock
-14.81-8.44-2.8-1.34--
Upgrade
Financing Cash Flow
-5.294.76296.64340.71.16270.49
Upgrade
Net Cash Flow
-54.25-106.29108.6-36.46-43.13-180.54
Upgrade
Free Cash Flow
-169.33-180.05-230.18-171.76-129.89-32.83
Upgrade
Free Cash Flow Margin
-77.09%-93.98%-4225.81%---93.81%
Upgrade
Free Cash Flow Per Share
-2.28-2.43-3.65-3.22-2.68-0.76
Upgrade
Levered Free Cash Flow
-94.37-111.54-113.19-88.27-63.42-16.15
Upgrade
Unlevered Free Cash Flow
-93.75-111.54-113.19-88.27-63.42-16.15
Upgrade
Change in Net Working Capital
20.629.62-12.38-23.62-8.08-3.06
Upgrade
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q